Overexpression of IL-3R  on CD34+CD38- stem cells defines leukemia-initiating cells in Fanconi anemia AML

Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm

(2010) R. B. Walter et al.   BLOOD

Mutation of the RAD51C gene in a Fanconi anemia–like disorder

(2010) Fiona Vaz et al.   NATURE GENETICS

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

(2010) Alfons Meindl et al.   NATURE GENETICS

Prognostic Factors in Pediatric Acute Myeloid Leukemia

(2010) Mohamed Radhi et al.   Current Hematologic Malignancy Reports

Another nail in the AML coffin

(2009) C. N. Abboud   BLOOD

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells

(2009) Liqing Jin et al.   Cell Stem Cell

Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology

(2009) B. Cate et al.   CURRENT DRUG TARGETS

Looking ahead in cancer stem cell research

(2009) John E Dick   NATURE BIOTECHNOLOGY

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML

(2008) Z. Zeng et al.   BLOOD

Combining SDF-1/CXCR4 antagonism and chemotherapy in relapsed acute myeloid leukemia

(2008) F A Fierro et al.   LEUKEMIA